Co-Authors
This is a "connection" page, showing publications co-authored by Georg Schett and David Simon.
Connection Strength
3.159
-
Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion. Arthritis Rheumatol. 2022 01; 74(1):33-37.
Score: 0.980
-
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2021 10; 80(10):1312-1316.
Score: 0.944
-
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
Score: 0.894
-
COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. 2020 08; 16(8):465-470.
Score: 0.222
-
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann Rheum Dis. 2021 Oct; 80(10):e161.
Score: 0.060
-
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. 2021 10; 80(10):1339-1344.
Score: 0.059